Company Filing History:
Years Active: 2014-2025
Title: Baltazar Gomez-Mancilla: Innovator in Neuropharmacology
Introduction
Baltazar Gomez-Mancilla is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of neuropharmacology, holding a total of eight patents. His work focuses on developing innovative treatments for cognitive impairments and alcohol use disorders.
Latest Patents
One of his latest patents is titled "Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment." This invention provides methods for predicting therapeutic responsiveness in subjects suffering from cognitive impairments or neurodegenerative disorders. Another notable patent is "Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use." This invention relates to the use of mavoglurant in reducing alcohol use and preventing relapse in patients with alcohol use disorders.
Career Highlights
Baltazar Gomez-Mancilla is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on groundbreaking research and development in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Donald Johns and Dominik Feuerbach, to advance research in his field.
Conclusion
Baltazar Gomez-Mancilla's innovative work in neuropharmacology and his contributions to the treatment of cognitive impairments and alcohol use disorders highlight his importance as an inventor. His patents reflect a commitment to improving patient outcomes through scientific advancements.